Jansen et al. speculate that the decrease in the lethality of T cells to tumors is due to the excessive number of depleted T cells with positive checkpoints or the high expression of PD-L1 in tumors, but that stem cell-like CD8+T cells form too few anti-tumor bases [37]. The gene discussed is CD8A; the disease is neoplasm.